IL17A and neoplasm: Recent clinical research has indicated that high IL-17A levels in early-stage colorectal cancer (stage I or II) correlate strongly with rapid tumor progression and metastasis, suggesting that IL-17A could serve as a reliable prognostic biomarker (Fakih et al., 2023).